{"entity":{"type":"insider","cik":"0001738048","url":"/insider/0001738048","json_url":"/insider/0001738048.json","name":"Venrock Healthcare Capital Partners III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":117,"n_filings":46,"first":"2018-09-07","last":"2026-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Venrock Healthcare Capital Partners III, L.P.","source":"filing","n_filings":46,"first_seen":"2018-09-07","last_seen":"2026-03-27"}],"transactions":[{"id":6179964,"accession":"0001231919-26-000286","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001231919-26-000286","line_url":"/filing/0001231919-26-000286#line-5","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21386.0,"shares_display":"21,386","price_per_share":17.76,"price_display":"17.76","price_state":"stated","total_value":379815.36,"total_display":"379,815.36","shares_owned_after":5107954.0,"shares_owned_after_display":"5,107,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":6179958,"accession":"0001231919-26-000286","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000286","line_url":"/filing/0001231919-26-000286#line-4","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15417.0,"shares_display":"15,417","price_per_share":18.82,"price_display":"18.82","price_state":"stated","total_value":290147.94,"total_display":"290,147.94","shares_owned_after":5092537.0,"shares_owned_after_display":"5,092,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":6179954,"accession":"0001231919-26-000286","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-26-000286","line_url":"/filing/0001231919-26-000286#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3183.0,"shares_display":"3,183","price_per_share":19.12,"price_display":"19.12","price_state":"stated","total_value":60858.96,"total_display":"60,858.96","shares_owned_after":5089354.0,"shares_owned_after_display":"5,089,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":6179950,"accession":"0001231919-26-000286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000286","line_url":"/filing/0001231919-26-000286#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174485.0,"shares_display":"174,485","price_per_share":16.95,"price_display":"16.95","price_state":"stated","total_value":2957520.75,"total_display":"2,957,520.75","shares_owned_after":5129500.0,"shares_owned_after_display":"5,129,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-27","scope":"insider"},{"id":6179945,"accession":"0001231919-26-000286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000286","line_url":"/filing/0001231919-26-000286#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160.0,"shares_display":"160","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":2804.8,"total_display":"2,804.80","shares_owned_after":5129340.0,"shares_owned_after_display":"5,129,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-27","scope":"insider"},{"id":4146364,"accession":"0001415889-25-010587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010587","line_url":"/filing/0001415889-25-010587#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":9.42,"price_display":"9.42","price_state":"stated","total_value":235500.0,"total_display":"235,500.00","shares_owned_after":5303985.0,"shares_owned_after_display":"5,303,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider"},{"id":4500384,"accession":"0001415889-25-005908","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-005908","line_url":"/filing/0001415889-25-005908#line-5","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88794.0,"shares_display":"88,794","price_per_share":11.44,"price_display":"11.44","price_state":"stated","total_value":1015803.36,"total_display":"1,015,803.36","shares_owned_after":4148428.0,"shares_owned_after_display":"4,148,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-27","scope":"insider"},{"id":5002998,"accession":"0001415889-25-004324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-004324","line_url":"/filing/0001415889-25-004324#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC; Shah Nimish P; Koh Bong Y; VHCP Management EG, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61700.0,"shares_display":"61,700","price_per_share":9.33,"price_display":"9.33","price_state":"stated","total_value":575661.0,"total_display":"575,661.00","shares_owned_after":5278985.0,"shares_owned_after_display":"5,278,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":4500378,"accession":"0001415889-25-005908","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-005908","line_url":"/filing/0001415889-25-005908#line-4","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14950.0,"shares_display":"14,950","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":173868.5,"total_display":"173,868.50","shares_owned_after":4059634.0,"shares_owned_after_display":"4,059,634","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-27","scope":"insider"},{"id":5002985,"accession":"0001415889-25-004324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-004324","line_url":"/filing/0001415889-25-004324#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC; Shah Nimish P; Koh Bong Y; VHCP Management EG, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":9.23,"price_display":"9.23","price_state":"stated","total_value":923000.0,"total_display":"923,000.00","shares_owned_after":5217285.0,"shares_owned_after_display":"5,217,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider"},{"id":4500374,"accession":"0001415889-25-005908","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-005908","line_url":"/filing/0001415889-25-005908#line-3","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8971.0,"shares_display":"8,971","price_per_share":11.86,"price_display":"11.86","price_state":"stated","total_value":106396.06,"total_display":"106,396.06","shares_owned_after":4044684.0,"shares_owned_after_display":"4,044,684","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-27","scope":"insider"},{"id":4885181,"accession":"0001415889-25-003665","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-003665","line_url":"/filing/0001415889-25-003665#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Co-Investment Holdings III, LLC; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26703.0,"shares_display":"26,703","price_per_share":9.18,"price_display":"9.18","price_state":"stated","total_value":245133.54,"total_display":"245,133.54","shares_owned_after":5117285.0,"shares_owned_after_display":"5,117,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-11","scope":"insider"},{"id":4500370,"accession":"0001415889-25-005908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-005908","line_url":"/filing/0001415889-25-005908#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9593.0,"shares_display":"9,593","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":105043.35,"total_display":"105,043.35","shares_owned_after":4035713.0,"shares_owned_after_display":"4,035,713","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-27","scope":"insider"},{"id":4885178,"accession":"0001415889-25-003665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003665","line_url":"/filing/0001415889-25-003665#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Co-Investment Holdings III, LLC; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4137.0,"shares_display":"4,137","price_per_share":9.14,"price_display":"9.14","price_state":"stated","total_value":37812.18,"total_display":"37,812.18","shares_owned_after":5090582.0,"shares_owned_after_display":"5,090,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-11","scope":"insider"},{"id":4500363,"accession":"0001415889-25-005908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005908","line_url":"/filing/0001415889-25-005908#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":574.0,"shares_display":"574","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":6256.6,"total_display":"6,256.60","shares_owned_after":4026120.0,"shares_owned_after_display":"4,026,120","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-27","scope":"insider"},{"id":4885175,"accession":"0001415889-25-003665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-003665","line_url":"/filing/0001415889-25-003665#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management III, LLC; VHCP Management EG, LLC; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Co-Investment Holdings III, LLC; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73649.0,"shares_display":"73,649","price_per_share":9.29,"price_display":"9.29","price_state":"stated","total_value":684199.21,"total_display":"684,199.21","shares_owned_after":5086445.0,"shares_owned_after_display":"5,086,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-07","filed_date":"2025-02-11","scope":"insider"},{"id":4588506,"accession":"0001415889-25-002809","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-002809","line_url":"/filing/0001415889-25-002809#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14562.0,"shares_display":"14,562","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":134261.64,"total_display":"134,261.64","shares_owned_after":5012796.0,"shares_owned_after_display":"5,012,796","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-03","scope":"insider"},{"id":4588502,"accession":"0001415889-25-002809","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002809","line_url":"/filing/0001415889-25-002809#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11754.0,"shares_display":"11,754","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":104493.06,"total_display":"104,493.06","shares_owned_after":4998234.0,"shares_owned_after_display":"4,998,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":4588499,"accession":"0001415889-25-002809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002809","line_url":"/filing/0001415889-25-002809#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43707.0,"shares_display":"43,707","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":382873.32,"total_display":"382,873.32","shares_owned_after":4986480.0,"shares_owned_after_display":"4,986,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-02-03","scope":"insider"},{"id":2743299,"accession":"0001415889-24-003118","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-003118","line_url":"/filing/0001415889-24-003118#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29747.0,"shares_display":"29,747","price_per_share":14.7,"price_display":"14.70","price_state":"stated","total_value":437280.9,"total_display":"437,280.90","shares_owned_after":4824731.0,"shares_owned_after_display":"4,824,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider"},{"id":2743294,"accession":"0001415889-24-003118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-003118","line_url":"/filing/0001415889-24-003118#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51827.0,"shares_display":"51,827","price_per_share":14.56,"price_display":"14.56","price_state":"stated","total_value":754601.12,"total_display":"754,601.12","shares_owned_after":4794984.0,"shares_owned_after_display":"4,794,984","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":2743289,"accession":"0001415889-24-003118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003118","line_url":"/filing/0001415889-24-003118#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4474.0,"shares_display":"4,474","price_per_share":14.74,"price_display":"14.74","price_state":"stated","total_value":65946.76,"total_display":"65,946.76","shares_owned_after":4743157.0,"shares_owned_after_display":"4,743,157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2130021,"accession":"0001415889-24-002183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002183","line_url":"/filing/0001415889-24-002183#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88099.0,"shares_display":"88,099","price_per_share":14.47,"price_display":"14.47","price_state":"stated","total_value":1274792.53,"total_display":"1,274,792.53","shares_owned_after":4738683.0,"shares_owned_after_display":"4,738,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-02-01","scope":"insider"},{"id":2709017,"accession":"0001415889-24-001941","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-001941","line_url":"/filing/0001415889-24-001941#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80600.0,"shares_display":"80,600","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":1146132.0,"total_display":"1,146,132.00","shares_owned_after":4650584.0,"shares_owned_after_display":"4,650,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-29","scope":"insider"},{"id":2709012,"accession":"0001415889-24-001941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-001941","line_url":"/filing/0001415889-24-001941#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4174.0,"shares_display":"4,174","price_per_share":12.98,"price_display":"12.98","price_state":"stated","total_value":54178.52,"total_display":"54,178.52","shares_owned_after":4569984.0,"shares_owned_after_display":"4,569,984","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-29","scope":"insider"},{"id":2709008,"accession":"0001415889-24-001941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-001941","line_url":"/filing/0001415889-24-001941#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; Shah Nimish P; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7030.0,"shares_display":"7,030","price_per_share":12.73,"price_display":"12.73","price_state":"stated","total_value":89491.9,"total_display":"89,491.90","shares_owned_after":4565810.0,"shares_owned_after_display":"4,565,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2595137,"accession":"0001415889-24-001781","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-001781","line_url":"/filing/0001415889-24-001781#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20686.0,"shares_display":"20,686","price_per_share":12.44,"price_display":"12.44","price_state":"stated","total_value":257333.84,"total_display":"257,333.84","shares_owned_after":4558780.0,"shares_owned_after_display":"4,558,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":2595134,"accession":"0001415889-24-001781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-001781","line_url":"/filing/0001415889-24-001781#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10897.0,"shares_display":"10,897","price_per_share":12.54,"price_display":"12.54","price_state":"stated","total_value":136648.38,"total_display":"136,648.38","shares_owned_after":4538094.0,"shares_owned_after_display":"4,538,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-24","scope":"insider"},{"id":2595129,"accession":"0001415889-24-001781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-001781","line_url":"/filing/0001415889-24-001781#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners EG, L.P.; Koh Bong Y; VHCP Management EG, LLC; VHCP Management III, LLC; VHCP Co-Investment Holdings III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67546.0,"shares_display":"67,546","price_per_share":12.55,"price_display":"12.55","price_state":"stated","total_value":847702.3,"total_display":"847,702.30","shares_owned_after":4527197.0,"shares_owned_after_display":"4,527,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":2248051,"accession":"0001209191-24-001957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-001957","line_url":"/filing/0001209191-24-001957#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Koh Bong Y; Shah Nimish P; VHCP Management III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":310750.0,"total_display":"310,750.00","shares_owned_after":4459651.0,"shares_owned_after_display":"4,459,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-19","scope":"insider"},{"id":2248045,"accession":"0001209191-24-001957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001957","line_url":"/filing/0001209191-24-001957#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Koh Bong Y; Shah Nimish P; VHCP Management III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39680.0,"shares_display":"39,680","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":496396.8,"total_display":"496,396.80","shares_owned_after":4434651.0,"shares_owned_after_display":"4,434,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-18","filed_date":"2024-01-19","scope":"insider"},{"id":2248041,"accession":"0001209191-24-001957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001957","line_url":"/filing/0001209191-24-001957#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Koh Bong Y; Shah Nimish P; VHCP Management III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78925.0,"shares_display":"78,925","price_per_share":12.6,"price_display":"12.60","price_state":"stated","total_value":994455.0,"total_display":"994,455.00","shares_owned_after":4394971.0,"shares_owned_after_display":"4,394,971","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":2382293,"accession":"0001209191-24-001666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001666","line_url":"/filing/0001209191-24-001666#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management EG, LLC; VHCP Management III, LLC; Koh Bong Y; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19599.0,"shares_display":"19,599","price_per_share":12.73,"price_display":"12.73","price_state":"stated","total_value":249495.27,"total_display":"249,495.27","shares_owned_after":4316046.0,"shares_owned_after_display":"4,316,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-16","scope":"insider"},{"id":2382291,"accession":"0001209191-24-001666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001666","line_url":"/filing/0001209191-24-001666#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Management EG, LLC; VHCP Management III, LLC; Koh Bong Y; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6647.0,"shares_display":"6,647","price_per_share":12.68,"price_display":"12.68","price_state":"stated","total_value":84283.96,"total_display":"84,283.96","shares_owned_after":4296447.0,"shares_owned_after_display":"4,296,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-16","scope":"insider"},{"id":2547185,"accession":"0001209191-24-001403","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-001403","line_url":"/filing/0001209191-24-001403#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47700.0,"shares_display":"47,700","price_per_share":12.67,"price_display":"12.67","price_state":"stated","total_value":604359.0,"total_display":"604,359.00","shares_owned_after":4289800.0,"shares_owned_after_display":"4,289,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-10","scope":"insider"},{"id":2547181,"accession":"0001209191-24-001403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001403","line_url":"/filing/0001209191-24-001403#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20816.0,"shares_display":"20,816","price_per_share":12.56,"price_display":"12.56","price_state":"stated","total_value":261448.96,"total_display":"261,448.96","shares_owned_after":4242100.0,"shares_owned_after_display":"4,242,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":2547175,"accession":"0001209191-24-001403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001403","line_url":"/filing/0001209191-24-001403#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Venrock Healthcare Capital Partners EG, L.P.; VHCP Management EG, LLC; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.; VHCP Management III, LLC; Koh Bong Y","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69184.0,"shares_display":"69,184","price_per_share":12.44,"price_display":"12.44","price_state":"stated","total_value":860648.96,"total_display":"860,648.96","shares_owned_after":4221284.0,"shares_owned_after_display":"4,221,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-10","scope":"insider"},{"id":2472584,"accession":"0001209191-24-001008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001008","line_url":"/filing/0001209191-24-001008#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; Koh Bong Y; VHCP Management III, LLC; Venrock Healthcare Capital Partners III, L.P.; VHCP Management EG, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41764.0,"shares_display":"41,764","price_per_share":12.11,"price_display":"12.11","price_state":"stated","total_value":505762.04,"total_display":"505,762.04","shares_owned_after":4152100.0,"shares_owned_after_display":"4,152,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":2472577,"accession":"0001209191-24-001008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001008","line_url":"/filing/0001209191-24-001008#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Shah Nimish P; Koh Bong Y; VHCP Management III, LLC; Venrock Healthcare Capital Partners III, L.P.; VHCP Management EG, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17605.0,"shares_display":"17,605","price_per_share":12.2,"price_display":"12.20","price_state":"stated","total_value":214781.0,"total_display":"214,781.00","shares_owned_after":4110336.0,"shares_owned_after_display":"4,110,336","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8297615,"accession":"0001209191-23-060015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-060015","line_url":"/filing/0001209191-23-060015#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6013.0,"shares_display":"6,013","price_per_share":12.49,"price_display":"12.49","price_state":"stated","total_value":75102.37,"total_display":"75,102.37","shares_owned_after":4092731.0,"shares_owned_after_display":"4,092,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2023-12-29","scope":"insider"},{"id":8297610,"accession":"0001209191-23-060015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-060015","line_url":"/filing/0001209191-23-060015#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":471490.0,"shares_display":"471,490","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":5893625.0,"total_display":"5,893,625.00","shares_owned_after":4086718.0,"shares_owned_after_display":"4,086,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2023-12-29","scope":"insider"},{"id":8297603,"accession":"0001209191-23-060015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-060015","line_url":"/filing/0001209191-23-060015#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41514.0,"shares_display":"41,514","price_per_share":11.97,"price_display":"11.97","price_state":"stated","total_value":496922.58,"total_display":"496,922.58","shares_owned_after":3615228.0,"shares_owned_after_display":"3,615,228","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":6186381,"accession":"0001209191-22-054671","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-054671","line_url":"/filing/0001209191-22-054671#line-3","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2367174.0,"shares_display":"2,367,174","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":1088900.04,"total_display":"1,088,900.04","shares_owned_after":3751406.0,"shares_owned_after_display":"3,751,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-26","scope":"insider"},{"id":6186377,"accession":"0001209191-22-054671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054671","line_url":"/filing/0001209191-22-054671#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1970418.0,"shares_display":"1,970,418","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":1123138.26,"total_display":"1,123,138.26","shares_owned_after":6118580.0,"shares_owned_after_display":"6,118,580","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-26","scope":"insider"},{"id":6186370,"accession":"0001209191-22-054671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054671","line_url":"/filing/0001209191-22-054671#line-1","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC; Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2113948.0,"shares_display":"2,113,948","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":1289508.28,"total_display":"1,289,508.28","shares_owned_after":8088998.0,"shares_owned_after_display":"8,088,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-26","scope":"insider"},{"id":6700483,"accession":"0001209191-22-054201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-054201","line_url":"/filing/0001209191-22-054201#line-3","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"Shah Nimish P; VHCP Management III, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":241366.0,"shares_display":"241,366","price_per_share":10.29,"price_display":"10.29","price_state":"stated","total_value":2483656.14,"total_display":"2,483,656.14","shares_owned_after":10132846.0,"shares_owned_after_display":"10,132,846","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-20","scope":"insider"},{"id":6700480,"accession":"0001209191-22-054201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054201","line_url":"/filing/0001209191-22-054201#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"Shah Nimish P; VHCP Management III, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70100.0,"shares_display":"70,100","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":788625.0,"total_display":"788,625.00","shares_owned_after":10202946.0,"shares_owned_after_display":"10,202,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-20","scope":"insider"},{"id":6700477,"accession":"0001209191-22-054201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054201","line_url":"/filing/0001209191-22-054201#line-1","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"Shah Nimish P; VHCP Management III, LLC; Koh Bong Y; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners II, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VHCP Management EG, LLC; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40400.0,"shares_display":"40,400","price_per_share":11.98,"price_display":"11.98","price_state":"stated","total_value":483992.0,"total_display":"483,992.00","shares_owned_after":9891480.0,"shares_owned_after_display":"9,891,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6399280,"accession":"0001209191-22-053863","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053863","line_url":"/filing/0001209191-22-053863#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners EG, L.P.; VHCP Co-Investment Holdings III, LLC; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":170292.0,"shares_display":"170,292","price_per_share":11.67,"price_display":"11.67","price_state":"stated","total_value":1987307.64,"total_display":"1,987,307.64","shares_owned_after":9851080.0,"shares_owned_after_display":"9,851,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-17","scope":"insider"},{"id":6399277,"accession":"0001209191-22-053863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053863","line_url":"/filing/0001209191-22-053863#line-1","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":null,"owner_name":"Shah Nimish P; Venrock Healthcare Capital Partners III, L.P.; Venrock Healthcare Capital Partners EG, L.P.; VHCP Co-Investment Holdings III, LLC; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Management EG, LLC; Koh Bong Y; VHCP Management III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4674.0,"shares_display":"4,674","price_per_share":11.98,"price_display":"11.98","price_state":"stated","total_value":55994.52,"total_display":"55,994.52","shares_owned_after":9680788.0,"shares_owned_after_display":"9,680,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"}],"next_cursor":"2022-10-13|6399277","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Ten percent owner","n_filings":15,"first_seen":"2019-03-20","last_seen":"2026-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"Oruka Therapeutics, Inc.","url":"/issuer/0000907654","role":"Ten percent owner","n_filings":1,"first_seen":"2025-02-27","last_seen":"2025-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001595585","name":"Tricida, Inc.","url":"/issuer/0001595585","role":"Ten percent owner","n_filings":20,"first_seen":"2022-06-06","last_seen":"2022-10-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001411685","name":"VistaGen Therapeutics, Inc.","url":"/issuer/0001411685","role":"Ten percent owner","n_filings":1,"first_seen":"2022-07-14","last_seen":"2022-07-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001622229","name":"Unum Therapeutics Inc.","url":"/issuer/0001622229","role":"Ten percent owner","n_filings":1,"first_seen":"2020-08-18","last_seen":"2020-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"Altimmune, Inc.","url":"/issuer/0001326190","role":"Ten percent owner","n_filings":2,"first_seen":"2020-05-28","last_seen":"2020-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2019-12-16","last_seen":"2019-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Ten percent owner","n_filings":5,"first_seen":"2018-09-07","last_seen":"2019-10-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738048","retrieved_at":"2026-08-21T00:01:32+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}